| CALC Market Cap History Table | ||||||||||||||||||||||||||||
Below is a table of the CALC market cap history going back to 6/14/2023:
Also see: CALC Shares Outstanding History and CALC YTD Return |
As of 8/5/2026 CalciMedica has a market cap of 25.30 million. Investors often follow the CALC market cap history to compare the size of the company over time.
This page shows CALC market capitalization trends over time, with 13 market cap datapoints presented, dating back to 6/14/2023.

| CALC Market Cap History Table | ||||||||||||||||||||||||||||
Below is a table of the CALC market cap history going back to 6/14/2023:
Also see: CALC Shares Outstanding History and CALC YTD Return |
| CALC Market Cap History Chart | |||||||||||||||||||||||||||||
CALC Historical Market Cap: -8.16% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||
| CALC Stock Price Chart |
| About CalciMedica Inc |
| CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies that inhibit calcium release-activated calcium (CRAC) channels to treat acute and chronic inflammatory and immunologic diseases. Its lead candidate, Auxora, is a selective intravenous small molecule CRAC channel inhibitor containing zegocractin, which has shown promise in reducing cell injury and inflammation in organs like the pancreas, lungs, and kidneys in animal models. The company is currently conducting a Phase 2b trial (CARPO) for acute pancreatitis with systemic inflammatory response syndrome and supporting a Phase 1/2 study on asparaginase-induced pancreatic toxicity (CRSPA). We show 13 historical shares outstanding datapoints in our CALC shares outstanding history coverage, used to compute CALC market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CALC market cap history over the course of time is important for investors interested in comparing CALC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CALC versus a peer is one thing; comparing CALC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CALC can fluctuate over the course of history. With this page we aim to empower investors researching CALC by allowing them to research the CALC market cap history. |
| CALC Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| CALC Share Performance |
| Market Cap Peers |
| CalciMedica (CALC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CANO Market Cap History CAPN Market Cap History CAPR Market Cap History CARA Market Cap History CARM Market Cap History CASI Market Cap History CASM Market Cap History CATB Market Cap History CATS Market Cap History CBAY Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.